Red Light Therapy: Pattern Thinning vs Scarring Loss
Which types of hair loss respond to red light therapy and who is a poor candidate?
Red light isn't a general hair loss treatment, and treating it like one is how people lose six months and a few hundred dollars. The whole question of candidacy comes down to a single physical fact: is there still a living follicle in the thinning area for the light to act on? If the follicle is gone, replaced by scar tissue, no wavelength and no dose brings it back.
Red light therapy has randomized sham-controlled support only in androgenetic hair loss graded roughly Norwood-Hamilton IIa to V in men and Ludwig-Savin I to II in women, and it can't regrow hair in scarred or long-dormant follicles because there's no living structure left for the light to act on.
What is the biological mechanism that makes low level light affect hair follicles?
The mechanism has a name, photobiomodulation, and a fairly well-mapped first step, even if the rest is still being worked out. What matters for you is that the light has to reach a hair bulb sitting below the surface of your scalp, and that the dose curve is biphasic rather than linear, so more power isn't automatically better.
- Absorption: Red light around 630 to 680 nanometers and near-infrared around 800 to 830 nanometers passes through tissue and gets absorbed by cytochrome c oxidase, the fourth complex in the mitochondrial chain.
- Release: The photon appears to displace nitric oxide that was sitting on the enzyme and holding it back.
- Energy lift: Electron transport picks up, ATP output rises, and you get a brief controlled bump in reactive oxygen species.
- Signalling: That bump triggers transcription factors tied to cell proliferation, nudging cells in the dermal papilla and the bulge region.
- Cycle shift: Resting follicles get pulled back into the growing phase, and follicles already growing stay in it longer.
Photobiomodulation raises ATP output in follicle cells and pushes resting follicles back into anagen, but it acts downstream of dihydrotestosterone rather than on it, so the hormonal driver of pattern thinning keeps working throughout treatment.
Which pattern of genetic thinning shows the strongest evidence of response?
Pattern hair loss is the only type with real randomized, sham-device-controlled human evidence behind it, and it's the reason home devices exist as a regulated category at all. The gains don't cluster tightly, so read the range rather than the headline number, and note that shaft thickness may matter more than hair count since thinning is a miniaturisation process before it's a disappearance.
Across the randomized sham-controlled trials, active groups gained roughly six to sixty-seven terminal hairs per square centimeter over sixteen to twenty-six weeks at the vertex and mid-scalp, with several trials also showing thicker shafts, and the effect is maintenance-dependent rather than a course with an endpoint.
Does light therapy help shedding triggered by stress, illness or childbirth?
Here's what most people get wrong about a big shed: it feels like an emergency, so it drives a purchase. Telogen effluvium isn't a reason to avoid a device, but it's rarely a good reason to buy one, because a systemic shock pushed a large share of your follicles into resting all at once and they're already programmed to come back.
- Delayed onset: Shedding shows up two to four months after the trigger, not right after it.
- Self-limiting: Most people recover most of their density within six months with no treatment.
- No trial evidence: No controlled studies exist here, so any improvement can't be attributed.
- Higher-value move: Ferritin, thyroid function, vitamin D and a medication review often find the cause.
Telogen effluvium follicles are alive and already programmed to re-enter growth, so the great majority of people recover most of their density without treatment within six months, and shedding that runs past six months points to a specialist opinion rather than a device.
Can light treatment restore hair in areas of scarring or permanent follicle loss?
No, and this is the firmest line in the whole subject. In a scarring alopecia the inflammation destroys the stem cell reservoir in the bulge region and fibrous tissue takes the follicle's place, so there's nothing left to stimulate. The real harm isn't the light itself, it's the months you spend waiting for a result that can't come while the destruction keeps spreading.
- Lost pore openings: Smooth shiny patches where the normal follicular openings have disappeared entirely.
- Perifollicular change: Redness or scaling around openings, or tufts of several hairs from one.
- Symptoms you can feel: Burning, itching or tenderness, which ordinary pattern thinning almost never causes.
- Advancing border: A distinct spreading edge instead of diffuse, gradual overall thinning.
In cicatricial alopecias such as lichen planopilaris, frontal fibrosing alopecia, central centrifugal cicatricial alopecia and folliculitis decalvans, the follicular unit has been replaced by fibrous tissue, so no wavelength or dose of light can regenerate it and the only realistic goal is halting the inflammation.
How does patchy autoimmune hair loss respond compared with pattern thinning?
These two conditions aren't related biologically, and mixing them up is a reliable route to disappointment. In patchy autoimmune loss the follicle is suppressed by an immune attack rather than destroyed, which is why hair can return years later from a patch that looked permanent, and it's also why a third to a half of people with limited disease regrow within a year no matter what they do.
| Criteria | Pattern thinning | Patchy autoimmune loss |
|---|---|---|
| Follicle state | Miniaturised, still cycling | Suppressed by T cells, not destroyed |
| Spontaneous recovery | Doesn't happen | A third to a half within a year |
| Evidence for light | Randomised sham-controlled trials | A handful of small uncontrolled studies |
| First-line options | Proven topical or oral medical treatment | Steroid injections, topical immunotherapy, oral JAK inhibitors |
Round, sharply defined, completely smooth patches with short tapered hairs at the edge point to autoimmune hair loss, which has its own better-supported treatment ladder aimed at the immune attack rather than at follicle metabolism.
What stage of thinning gives the best odds of a visible result?
Timing beats almost every other variable you can control, because pattern loss is a slow miniaturisation rather than a switch that flips. Under pressure from dihydrotestosterone, each cycle produces a shorter, finer hair, and light works best on follicles still cycling somewhere in the middle of that slide. It's a push toward growth, not a rebuild.
Photobiomodulation only works where miniaturised follicles are still cycling, so scalp showing visible fine or wispy hair responds while a surface that's been completely smooth for years does not, and a zoomed-in photo in bright light is a reliable way to tell which you have.
Which medical conditions and medications make someone a poor candidate?
Home devices have a good safety record, with trial side effects mostly limited to mild temporary dry skin, itching, headache or hives, so the exclusions are about specific situations rather than broad danger. Pregnancy and breastfeeding are generally advised against too, which reflects missing study data rather than proven harm, and you shouldn't look directly into the emitters.
- Photosensitivity: Lupus, porphyria or polymorphous light eruption, plus photosensitizing drugs like doxycycline and isotretinoin.
- Active scalp disease: Open sores, infection, inflamed dermatitis or psoriasis, or any changing pigmented lesion.
- Scalp cancer history: Photodynamic therapy or radiotherapy to the head needs oncology input first.
- Untreated deficiency: Thyroid disease, low iron or poorly controlled diabetes will blunt any response.
Photosensitizing conditions and medications, including tetracyclines, sulfonamides, fluoroquinolones, retinoids, amiodarone and some diuretics and antipsychotics, are the clearest reason to check with a prescriber before starting, and any mole, changing lesion or non-healing patch on the scalp needs a dermatologist rather than a light source held over it.
Why do some people see no change after months of consistent use?
I don't want you spending a year on the wrong problem, so separate the failure modes before you decide whether to keep going, change something or stop. They look identical from the outside, and only one of them means the device itself was the wrong call.
Meaningful change is rarely visible before four months and often not until six, and because untreated pattern loss is progressive, a scalp that looks unchanged after a year may be a genuine result rather than a failure, but six to twelve months of correct use over the right area with neither regrowth nor stabilisation calls for a diagnostic review.
How should someone confirm the cause of their hair loss before buying a device?
Getting the diagnosis right first is the highest-value thing you can do, because every candidacy question collapses into it. Against several hundred dollars for a device and six months of daily use, a consultation is cheap, and it usually gives you something better than a yes or no.
- Read your own scalp: Note whether the loss is diffuse or patchy, whether the part is widening or the temples are receding, whether hairs come out at the root with a white bulb or break along the shaft, and what happened three to four months before the shedding started.
- Start a photo record: Fixed angles, consistent light, at the start and monthly after. This is worth more than your memory of how it looked.
- Get dermoscopy: Magnification shows variation in shaft diameter that confirms miniaturisation, yellow and black dots and exclamation-mark hairs that point to autoimmune loss, and loss of follicular openings that signals scarring.
- Run the bloods: Ferritin, full blood count, thyroid function including TSH, vitamin D, and in women with signs of excess androgen, testosterone and DHEAS.
- Biopsy when the picture is unclear: A four millimeter punch biopsy is reserved for suspected scarring or an uncertain diagnosis, and it's the definitive test there.
Dermoscopy plus a blood panel covering ferritin, full blood count, thyroid function, vitamin D and androgens where indicated identifies the cause in most cases, and anything that looks scarring, spreads rapidly, is painful or inflamed, or appears suddenly in a child should be seen promptly rather than watched.
